Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 3Inflammation 2Frailty 2Small Cell Lung Carcinoma 1Radiodermatitis 1Prostatic Neoplasms 1Papillomavirus Infections 1Low-Grade Intraepithelial Neoplasia of Cervix 1Liver Neoplasms 1Liver Cirrhosis 1Fibrosis 1Esophageal Neoplasms 1Deglutition Disorders 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Low-Level Light Therapy 7Standard of Care 4triethanolamine 2sapropterin 2Sodium Chloride 2Curcumin 2Biafine 2eucerin 1epigallocatechin gallate 1cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1calcipotriene 1Zinc Oxide 1Triamcinolone Acetonide 1Thioctic Acid 1Sodium Hypochlorite 1Silver Sulfadiazine 1Radiotherapy 1Practice Guidelines as Topic 1Petrolatum 1Melatonin 1Laser Therapy 1Hydrogel, Polyethylene Glycol Dimethacrylate 1Hydrocortisone 1Gels 1Dimethyl Sulfoxide 1Centella asiatica extract 1Catechin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Radiodermatitis × epigallocatechin gallate × Clear all
NCT07149506 2025-09-08

OCTOPUS-RD

Universidad de Guanajuato

Phase 3 Enrolling by invitation
162 enrolled

Fibrosis, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡